PGF medicine distributor grows faster than the market

APA - Austria Presse Agentur
opublikowano: 04-03-2005, 14:03

Warsaw (Puls Biznesu) – Polska Grupa Farmaceutyczna (PGF), Polish leading medicine distributor controlling around 20 percent of the market, still wants to grow faster than the market, Jacek Szwajcowski, its CEO said. ‘This year’s medicine market growth is estimated at 8-9 percent. I expect us to achieve double-digit growth rate’, Jacek Szwajcowski said.

Warsaw (Puls Biznesu) – Polska Grupa Farmaceutyczna (PGF), Polish leading medicine distributor controlling around 20 percent of the market, still wants to grow faster than the market, Jacek Szwajcowski, its CEO said. ‘This year’s medicine market growth is estimated at 8-9 percent. I expect us to achieve double-digit growth rate’, Jacek Szwajcowski said. Last year, PGF had PLN 41.36 m (EUR 10.5 m) of net income against sales of over PLN 3.6 billion. The results were, respectively, 13 percent and 4.7 percent higher than in 2003.

Only rival Torfarm had faster sales rate: it was PLN 200 m more than in 2003, while PGF increased it by PLN 160 m. ‘The group’s income would be higher by PLN 7 m, hadn’t we invested in Cefarm Lodz. We will finish restructuring of the company this year’, PGF CEO explained. 12 percent of PGF sales are generated from trade with hospitals, which owe the company around PLN 100 m.

(PLN 1 = EUR 0.255)Poland/Enterprises/Healthcare

 

© ℗
Rozpowszechnianie niniejszego artykułu możliwe jest tylko i wyłącznie zgodnie z postanowieniami „Regulaminu korzystania z artykułów prasowych” i po wcześniejszym uiszczeniu należności, zgodnie z cennikiem.

Podpis: APA - Austria Presse Agentur

Polecane